[F-18]2-fluoro-2-doxyglucose (FDG) and C-11-methionine (C-11 MET) positron emission tomography (PET) versus conventional imaging modalities (CIM) in patients with newly progressing metastatic prostate cancer Meeting Abstract

  


Authors: Nunez, R.; Macapinlac, H.; Yeung, H. W. D.; Akhurst, T.; Finn, R. D.; Osman, I.; Petrisko, R.; Scher, H. I.; Larson, S. M.
Abstract Title: [F-18]2-fluoro-2-doxyglucose (FDG) and C-11-methionine (C-11 MET) positron emission tomography (PET) versus conventional imaging modalities (CIM) in patients with newly progressing metastatic prostate cancer
Meeting Title: 1999 Congress of the European Association of Nuclear Medicine (EANM)
Journal Title: European Journal of Nuclear Medicine
Volume: 26
Issue: 9
Meeting Dates: 1999 Oct 9-13
Meeting Location: Barcelona, Spain
ISSN: 0340-6997
Publisher: Springer Verlag  
Date Published: 1999-09-01
Start Page: 1017
Language: English
ACCESSION: WOS:000082614100229
PROVIDER: wos
DOI: 10.1007/BF02952180
PUBMED: 10546676
Notes: Meeting Abstract: OS-227 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Rodolfo F Nunez
    15 Nunez
  2. Henry W D Yeung
    126 Yeung
  3. Iman Osman
    36 Osman
  4. Ronald D Finn
    279 Finn
  5. Homer Macapinlac
    106 Macapinlac
  6. Timothy J Akhurst
    139 Akhurst
  7. Steven M Larson
    958 Larson
  8. Howard Scher
    1130 Scher
  9. Richard N Petrisko
    1 Petrisko
Related MSK Work